Kuros Biosciences Ltd. (CSBTF)
26.99
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Kuros Biosciences Total Liabilities (Quarterly)
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2013 | 51.84M |
| September 30, 2013 | 40.09M |
| June 30, 2013 | 33.78M |
| March 31, 2013 | 31.60M |
| December 31, 2012 | 32.62M |
| September 30, 2012 | 33.08M |
| June 30, 2012 | 29.26M |
| March 31, 2012 | 25.54M |
| December 31, 2011 | 51.91M |
| September 30, 2011 | 59.52M |
| June 30, 2011 | 62.61M |
| March 31, 2011 | 58.53M |
| December 31, 2010 | 57.80M |
| September 30, 2010 | 54.28M |
| June 30, 2010 | 48.03M |
| March 31, 2010 | 56.50M |
| December 31, 2009 | 65.88M |
| September 30, 2009 | 75.94M |
| June 30, 2009 | 74.62M |
| March 31, 2009 | 76.45M |
| December 31, 2008 | 82.05M |
| September 30, 2008 | 78.01M |
| June 30, 2008 | 74.41M |
| Date | Value |
|---|---|
| March 31, 2008 | 77.27M |
| December 31, 2007 | 68.50M |
| September 30, 2007 | 65.48M |
| June 30, 2007 | 90.27M |
| March 31, 2007 | 62.44M |
| December 31, 2006 | 9.431M |
| September 30, 2006 | 8.223M |
| June 30, 2006 | 6.710M |
| March 31, 2006 | 6.510M |
| December 31, 2005 | |
| September 30, 2005 | |
| June 30, 2005 | |
| March 31, 2005 | |
| December 31, 2004 | 7.203M |
| September 30, 2004 | 7.068M |
| June 30, 2004 | 5.759M |
| March 31, 2004 | 7.745M |
| December 31, 2003 | 6.655M |
| September 30, 2003 | 6.628M |
| June 30, 2003 | 6.904M |
| March 31, 2003 | 9.702M |
| December 31, 2002 | |
| September 30, 2002 | 3.629M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Molecular Partners AG | 21.27M |
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 3.973B |
| AC Immune SA | 142.85M |